Roche receives US emergency approval for coronavirus vs. flu test
Roche receives US emergency approval for coronavirus vs. flu test
“With the approaching flu season, this new test is particularly important as SARS-CoV-2 and influenza infections can hardly be differentiated by symptoms alone"
FILE PHOTO: The logo of Swiss drugmaker Roche is seen at its headquarters in Basel, Switzerland January 30, 2020. REUTERS/Arnd Wiegmann/File Photo
Drugmaker Roche on Friday said it had received Emergency Use Authorization from the US Food and Drug Administration for a test to quickly detect whether a patient has SARS-CoV-2 or one of two forms of influenza
"With the approaching flu season, this new test is particularly important as SARS-CoV-2 and influenza infections can hardly be differentiated by symptoms alone. Now, with a single test, healthcare professionals can confidently provide the right diagnosis and most effective treatment plan for their patients," Roche diagnostics head Thomas Schinecker said in a statement.
